Hsbc Holdings PLC Alkermes Plc. Transaction History

Hsbc Holdings PLC

$168 Billion
Q4 2024

A detailed history of Hsbc Holdings PLC transactions in Alkermes Plc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 29,663 shares of ALKS stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,663

Previous 13,129 125.93%

Holding current value

$1.05 Million

Previous $367,000 132.43%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$25.7 - $31.46 $424,923 - $520,159	16,534 Added 125.93%	29,663 $853,000
Q3 2024 Nov 14, 2024	BUY	$23.01 - $28.55 $302,098 - $374,832	13,129 New	13,129 $367,000
Q1 2024 May 15, 2024	BUY	$26.4 - $32.56 $1.23 Million - $1.52 Million	46,644 Added 167.37%	74,512 $2.02 Million
Q4 2023 Feb 12, 2024	SELL	$23.37 - $28.68 $1.5 Million - $1.84 Million	-64,103 Reduced 69.7%	27,868 $773,000
Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $1.47 Million - $1.73 Million	54,231 Added 143.7%	91,971 $2.58 Million
Q2 2023 Aug 11, 2023	BUY	$28.34 - $33.63 $472,371 - $560,544	16,668 Added 79.1%	37,740 $1.18 Million
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $187,344 - $214,806	7,402 Added 54.15%	21,072 $594,000
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $299,919 - $358,700	13,670 New	13,670 $357,000
Q2 2022 Aug 11, 2022	SELL	$26.4 - $30.54 $841,816 - $973,828	-31,887 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $186,267 - $225,991	8,074 Added 33.91%	31,887 $853,000
Q4 2021 Feb 11, 2022	BUY	$21.47 - $32.08 $76,776 - $114,718	3,576 Added 17.67%	23,813 $553,000
Q3 2021 Nov 12, 2021	SELL	$23.37 - $32.13 $196,097 - $269,602	-8,391 Reduced 29.31%	20,237 $627,000
Q2 2021 Aug 13, 2021	SELL	$18.78 - $25.15 $150,108 - $201,023	-7,993 Reduced 21.83%	28,628 $701,000
Q1 2021 May 14, 2021	SELL	$18.21 - $23.2 $84,275 - $107,369	-4,628 Reduced 11.22%	36,621 $684,000
Q4 2020 Feb 12, 2021	SELL	$15.39 - $22.1 $18,329 - $26,321	-1,191 Reduced 2.81%	41,249 $822,000
Q3 2020 Nov 12, 2020	BUY	$16.16 - $20.66 $15,028 - $19,213	930 Added 2.24%	42,440 $704,000
Q2 2020 Aug 14, 2020	BUY	$13.31 - $19.41 $552,498 - $805,709	41,510 New	41,510 $806,000
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $327,988 - $533,421	-25,114 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$17.29 - $21.74 $925,239 - $1.16 Million	-53,513 Reduced 68.06%	25,114 $513,000
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $698,067 - $868,738	-35,780 Reduced 31.27%	78,627 $1.53 Million
Q2 2019 Aug 13, 2019	BUY	$21.47 - $37.33 $2.46 Million - $4.27 Million	114,407 New	114,407 $2.58 Million
Q4 2018 Feb 13, 2019	SELL	$27.94 - $44.61 $154,228 - $246,247	-5,520 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$38.6 - $46.12 $213,072 - $254,582	5,520 New	5,520 $235,000
Q1 2018 May 11, 2018	SELL	$53.61 - $67.26 $867,463 - $1.09 Million	-16,181 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $110,831 - $128,726	2,324 Added 16.77%	16,181 $885,000
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $681,210 - $754,513	13,857	13,857 $704,000

Others Institutions Holding ALKS

# of Institutions

376

Shares Held

173M

Call Options Held

231K

Put Options Held

158K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.79B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Alkermes Plc. Transaction History